MTOR and urinary bladder carcinoma: FIN56 could promote autophagy-mediated GPX4 degradation and induce the ferroptosis of bladder cancer cells, and FIN56 and the mTOR inhibitor Torin 2 synergistically killed bladder cancer cells [42].